Jon Napitupulu

Shattuck Labs has submitted an Investigational New Drug (IND) application for SL-325, its lead Death Receptor 3 (DR3) blocking...

Eledon Pharmaceuticals’ recent Q2 2025 update reveals encouraging progress for its lead candidate, tegoprubart, an anti-CD40L antibody, in the...

Inhibikase Therapeutics is advancing IKT-001, a prodrug of imatinib mesylate, toward a Phase 2b clinical trial for the treatment...

Annexon Biosciences’ recent corporate update reveals a company aggressively navigating the complex landscape of complement-mediated drug development, with a...

Camp4 Therapeutics, a clinical-stage biotech focused on RNA-targeting therapeutics, has released its Q2 2025 financial results alongside promising preclinical...

Macrogenics Charts a Course Toward Focused Growth and Enhanced Capital Efficiency Macrogenics, a clinical-stage biopharmaceutical company specializing in antibody-based...

Life Biosciences Forges Singapore Alliance to Advance Epigenetic Reprogramming for Age-Related Diseases Life Biosciences’ recent memorandum of understanding with...

Sanofi’s acquisition of ViceBio for an upfront payment of $1.15 billion, plus potential milestones, signifies a strategic move to...

Liminatus Pharma, a preclinical-stage biotech company, is exploring the integration of regulated digital assets into its treasury management strategy....

BioCardia and CART-Tech Partner to Advance Heart3D Fusion Imaging for Biotherapeutic Delivery BioCardia and CART-Tech have announced an exclusive...